
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

